Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 7006 AL 7020

New antipsychotic drugs for the treatment of agitation and psychosis in Alzheimer's disease: focus on brexpiprazole and pimavanserin

Caraci F, Santagati M, Caruso G, Cannavò D, Leggio GM, Salomone S, Drago F.

F1000Res. 2020 Jul 8;9:F1000 Faculty Rev-686. doi: 10.12688/f1000research.22662.1. eCollection 2020.

Current Aspects of the Endocannabinoid System and Targeted THC and CBD Phytocannabinoids as Potential Therapeutics for Parkinson's and Alzheimer's Diseases: a Review

Cooray R, Gupta V, Suphioglu C.

Mol Neurobiol. 2020 Nov;57(11):4878-4890. doi: 10.1007/s12035-020-02054-6. Epub 2020 Aug 19.

Potential Role of Natural Polyphenols against Protein Aggregation Toxicity: In Vitro, In Vivo, and Clinical Studies

Henríquez G, Gomez A, Guerrero E, Narayan M.

ACS Chem Neurosci. 2020 Oct 7;11(19):2915-2934. doi: 10.1021/acschemneuro.0c00381. Epub 2020 Sep 11.

Antidiabetic drugs for Alzheimer's and Parkinson's diseases: Repurposing insulin, metformin, and thiazolidinediones

Cardoso S, Moreira PI.

Int Rev Neurobiol. 2020;155:37-64. doi: 10.1016/bs.irn.2020.02.010. Epub 2020 Aug 11.

Early-start vs delayed-start donepezil against cognitive decline in Parkinson disease: a randomized clinical trial

Sawada H, Oeda T, Kohsaka M, Tomita S, Umemura A, Park K, Yamamoto K, Kiyohara K.

Expert Opin Pharmacother. 2021 Feb;22(3):363-371. doi: 10.1080/14656566.2020.1814255. Epub 2020 Aug 31.

Challenges and Opportunities of Deferoxamine Delivery for Treatment of Alzheimer's Disease, Parkinson's Disease, and Intracerebral Hemorrhage

Farr AC, Xiong MP.

Mol Pharm. 2021 Feb 1;18(2):593-609. doi: 10.1021/acs.molpharmaceut.0c00474. Epub 2020 Oct 9.

Redox-Responsive Nanobiomaterials-Based Therapeutics for Neurodegenerative Diseases

Eleftheriadou D, Kesidou D, Moura F, Felli E, Song W.

Small. 2020 Oct;16(43):e1907308. doi: 10.1002/smll.201907308. Epub 2020 Sep 17.

A comprehensive review of monoamine oxidase inhibitors as Anti-Alzheimer's disease agents: A review

Manzoor S, Hoda N.

Eur J Med Chem. 2020 Nov 15;206:112787. doi: 10.1016/j.ejmech.2020.112787. Epub 2020 Sep 1.

Neuroinflammation

Mukhara D, Oh U, Neigh GN.

Handb Clin Neurol. 2020;175:235-259. doi: 10.1016/B978-0-444-64123-6.00017-5.

Challenges and opportunities for improving the landscape for Lewy body dementia clinical trials

Goldman JG, Forsberg LK, Boeve BF, Armstrong MJ, Irwin DJ, Ferman TJ, Galasko D, Galvin JE, Kaufer D, Leverenz J, Lippa CF, Marder K, Abler V, Biglan K, Irizarry M, Keller B, Munsie L, Nakagawa M, Taylor A, Graham T.

Alzheimers Res Ther. 2020 Oct 29;12(1):137. doi: 10.1186/s13195-020-00703-5.

Application of Contemporary Neuroproteomic Techniques in Unravelling Neurological Disorders

Khurana M, Rahman SO, Najmi AK, Pottoo FH, Akhtar MS.

Curr Protein Pept Sci. 2020;21(12):1146-1163. doi: 10.2174/1389203721666201104130135.

Treating brain diseases using systemic parenterally-administered protein therapeutics: Dysfunction of the brain barriers and potential strategies

Zaghmi A, Drouin-Ouellet J, Brambilla D, Gauthier MA.

Biomaterials. 2021 Feb;269:120461. doi: 10.1016/j.biomaterials.2020.120461. Epub 2020 Nov 6.

Target Enzymes Considered for the Treatment of Alzheimer's Disease and Parkinson's Disease

Kim N, Lee HJ.

Biomed Res Int. 2020 Nov 9;2020:2010728. doi: 10.1155/2020/2010728. eCollection 2020.

Effects of Ketone Bodies on Brain Metabolism and Function in Neurodegenerative Diseases

Jensen NJ, Wodschow HZ, Nilsson M, Rungby J.

Int J Mol Sci. 2020 Nov 20;21(22):8767. doi: 10.3390/ijms21228767.

Impact of arterial hypertension and its management strategies on cognitive function and dementia: a comprehensive umbrella review

Antonazzo B, Marano G, Romagnoli E, Ronzoni S, Frati G, Sani G, Janiri L, Mazza M.

Minerva Cardiol Angiol. 2022 Jun;70(3):285-297. doi: 10.23736/S2724-5683.20.05452-3. Epub 2020 Dec 1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias